Neupro 8mg/24h Patches / Transdermal
Rotigotine
18mg
UCB MANUFACTURING IRELAND LTD.
| Pack size | 28 Patches |
|---|---|
| Dispensing mode | POM |
| Source | IRELAND |
| Agent | Modern Pharmaceutical Co. |
| Retail Price | 828.50 AED |
Available as:
Indications
Neupro 8mg/24h Patches / Transdermal is used for:
For use/treatment in neurologic disorders and parkinson's disease as well as moderate-to-severe primary restless legs syndrome
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Rotigotine :
Mechanism of Action
Rotigotine, a member of the dopamine agonist class of drugs, is delivered continuously through the skin (transdermal) using a silicone-based patch that is replaced every 24 hours. A dopamine agonist works by activating dopamine receptors in the body, mimicking the effect of the neurotransmitter dopamine. The precise mechanism of action of rotigotine as a treatment for restless legs syndrome is unknown but is thought to be related to its ability to stimulate dopamine
Note
Neupro 8mg/24h 18mg Patches / Transdermal manufactured by UCB MANUFACTURING IRELAND LTD.. Its generic name is Rotigotine. Neupro 8mg/24h is availble in United Arab Emirates.
Farmaco UAE drug index information on Neupro 8mg/24h Patches / Transdermal is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.